loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 17a8d11b 73b0 4833 A0b4 Cf1ef85edefb Applno 207533 Form Suspension Extended Release Intramuscular Dosage 882mg 3 2ml 275 63mg Ml - Drug Product Composition: Aripiprazole Lauroxil

    Menu

    Aripiprazole Lauroxil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 33,034Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 207533 / DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 882MG/3.2ML (275.63MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    aripiprazole lauroxil(UNII: B786J7A343)
    (aripiprazole lauroxil - UNII:B786J7A343)     		aripiprazole lauroxil882mg in 3.2 | 1064mg in 3.9 | 441mg in 1.6 | 662mg in 2.4

    Inactive Ingredients

    Ingredient Name
    Alkermes, Inc.
    Polysorbate 20(7T1F30V5YH)
    Sodium Chloride(451W47IQ8X)
    Sodium Phosphate, Dibasic, Anhydrous(22ADO53M6F)
    Sodium Phosphate, Monobasic, Dihydrate(5QWK665956)
    Sorbitan Monolaurate(6W9PS8B71J)
    Water(059QF0KO0R)